Ms. Tellado joined Corcept as President of Emerging Markets in November 2023 with more than two decades of experience, including executive roles in finance, commercial operations, marketing, and sales. Ms. Tellado served as Chief Financial Officer of Heartflow, and Senior Vice President of Finance and Investor Relations at Gilead Sciences. While at Gilead Sciences, she also served as Vice President of Sales and Marketing for the company’s Liver Disease Business Unit; and Vice President of Commercial Operations, where she led efforts to launch products across HIV, liver diseases, cardiopulmonary diseases, and oncology.

Ms. Tellado was recognized by the San Francisco Business Times as one of the Most Influential Women in Business in 2018. She holds an MBA in Finance and Marketing from Carnegie Mellon University and a B.S. in European Business Administration with a concentration in finance from Universidad Pontificia Comillas.